Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 0.0 | BCD100322A002 | 14.4 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 0.5 | BCD100322A005 | 11 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 1.0 | BCD100322A009 | 14.9 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 2.0 | BCD100322A013 | 12.1 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 4.0 | BCD100322A017 | 11.4 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 8.0 | BCD100322A021 | 10.8 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 12.0 | BCD100322A025 | 8.54 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | Lipid-depleted/compactin | 24.0 | BCD100322A029 | 8.47 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 0.0 | BCD100322A001 | 16.2 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 0.5 | BCD100322A003 | 13.1 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 1.0 | BCD100322A007 | 14.6 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 2.0 | BCD100322A011 | 11.1 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 4.0 | BCD100322A015 | 15.9 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 8.0 | BCD100322A019 | 19.7 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 12.0 | BCD100322A023 | 16.8 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | C | 24.0 | BCD100322A027 | 15.7 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A006 | 15.8 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A010 | 10.8 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A014 | 10.9 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A018 | 11.7 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A022 | 8.81 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A026 | 16.1 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A030 | 14.8 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 0.5 | BCD100322A004 | 12.1 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 1.0 | BCD100322A008 | 9.8 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 2.0 | BCD100322A012 | 9.34 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 4.0 | BCD100322A016 | 13.7 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 8.0 | BCD100322A020 | 13.5 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 12.0 | BCD100322A024 | 14.3 | pmol/sample |
| LMFA01030178 | 7Z,10Z,13Z,16Z-docosatetraenoic acid | 25OH-Chol | 24.0 | BCD100322A028 | 9.04 | pmol/sample |